Donald W. DeGolyer, Director at Emergent BioSolutions Inc. (EBS), sold 15,688 shares at $8.65 ($136K) on 2025-08-12, disclosed to the SEC on 2025-08-13.
Open-market sale of $136k EBS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.65 | 7,844 | $68K | 50.0% |
| 2 | $8.65 | 7,844 | $68K | 50.0% |
| Total | $8.65 avg | 15,688 | $136K | 100% |
| Filing → |
| EBS | SELL | 2025-11-12 | $375K | — | Filing → |
| EBS | SELL | 2024-11-14 | $273K | — | Filing → |